Business Wire

CA-FAUNA

7.7.2021 15:02:05 CEST | Business Wire | Press release

Share
With Global Demand Growing, Fauna Launches New Region Groups, Achieves SOC 2 Compliance, and Adds Sales Leader to Further Accelerate Company Momentum

Fauna , the data API for modern applications, today announced the availability of a new US and European Region Groups and attainment of SOC 2 compliance to support the data residency and regulatory compliance needs of customers. The company also announced the addition of new sales leadership with deep developer and enterprise sales experience. The combination of these new features and sales leadership will help accelerate customer adoption of Fauna globally.

Thus far in 2021 Fauna has experienced 200+% growth in new customers in over 50 countries around the globe. Leveraging Fauna, these companies are bringing disruptive new applications to market more quickly by leaning heavily on the developer productivity that Fauna brings to the table, as well as by foregoing the need to care for and feed traditional database infrastructure.

“As our customer base has grown globally and larger organizations have begun adopting Fauna, it is critical for us to provide additional levels of compliance and more fine grained ways in which customers can manage their data residency needs within Fauna,” said Eric Berg, CEO of Fauna. “The combination of SOC2 compliance and our new Region Groups architecture allows us to meet those needs while still delivering a great developer experience and the zero database operations approach our customers love. Matt Slagle’s addition to the team to scale sales and build out a vibrant partner ecosystem also adds the right leadership and focus to accelerate our business by ensuring customers globally are successful with Fauna.”

New Geographic Region Groups

Unique to Fauna, its new Region Group capability allows global brands to meet local data residency requirements without compromising the performance, latency and reliability gained from distributing data across multiple cloud regions across a geography. Moreover, Region Groups control has been added to the zero operations experience that customers love about Fauna - no database operations required.

Countries around the world have introduced data sovereignty and privacy laws such as the GDPR that require companies to keep application data within the same area from which it was generated. However, to make applications more performant, and resilient, companies also want to bring data closer to their users across multiple cloud regions.

“App developers want to focus on building the app, not worrying about regional and international regulations and restrictions, or building high availability and redundancy services across modern distributed infrastructures,” said James Governor, co-founder of Redmonk. “Making control of data residency easy in specific geographical regions will make life much easier for developers.”

Fauna’s new capabilities address these requirements by enabling companies to pin their databases to a specific geographic area, called a Region Group. Within each Region Group, Fauna automatically distributes and scales these databases across multiple cloud regions within that area to minimize query latency while ensuring data resiliency. All of this is done without any operational overhead for a Fauna customer, continuing to deliver on our zero database operations promise.

Customers have the flexibility to mix and match Region Groups and create databases where the business demands. Developers can start locally within a single Region Group, and add new databases in additional geographic areas as their customer base grows globally.

“Fauna’s new Region Groups break new ground in how and where data is stored and scaled, which has a major impact on performance and data privacy,” said Hassen Karaa, Vice President of Product for Fauna. “We’ve put the right data infrastructure in place in each geographic region to meet our growing customer needs. Moreover, we manage it transparently so that our customers can focus on building applications that scale and comply with their data privacy local regulations and laws.”

SOC 2 Compliance

Data security, availability, confidentiality and reliability are critical considerations for businesses using public cloud infrastructure and SaaS vendors. As a cloud-native API Fauna was built with these in mind.

To demonstrate commitment to these principles Fauna chose the AICPA SOC2 framework of controls and is now SOC 2 Type 1 compliant. Fauna's service commitments and system requirements were achieved based on the trust services criteria relevant to security, availability, and confidentiality. A Type 1 report is available under NDA.

“As we continue to grow our services rapidly across the world, complying with local privacy regulations and data security is essential to our expansion, especially since we work with governments,” said Felix Engelhardt, Lead Engineer at EIDU. “Our use of Fauna has significantly accelerated our ability to bring ideas to market, and the new features being introduced today are critical to support our growth. We applaud Fauna’s innovation and responsiveness to our needs for compliance.”

New Sales Leadership to Drive Customer Success

As part of the company’s efforts to accelerate customer success, Fauna has hired Matt Slagle as its new Vice President of Sales. Slagle joins Fauna from New Relic, where he helped grow the company from less than 100 employees and under $10M in revenue to 2200 employees and ~$700M ARR. In his most recent role he was a Group Vice President of Sales managing a 140 person team that generated $100M+ in revenue.

“I joined Fauna because I recognized the company’s potential to be a major force in data management and app development via a developer focused go to market,” said Slagle. “Customers today love the developer experience and zero database operations that Fauna delivers and I am excited to join the team and help accelerate the focus on customer success.”

About Fauna

Fauna is the data API for modern applications. With Fauna, developers can simplify code, reduce costs, and ship applications faster by replacing their database infrastructure with a highly productive and programmable data API that combines the power of custom business logic with the ease of GraphQL. The underlying globally distributed storage and compute engine is fast, consistent, and reliable, with a modern security infrastructure. Itself a serverless offering, Fauna is quick to get started with and lets developers experience freedom from database operations at any scale. Innovators like Hannon Hill, ShiftX, DigitalAX, and MeetKai trust Fauna to power their applications. Backed by premier venture investors Madrona Venture Group, ADDITION, GV, and CRV, Fauna is headquartered in San Francisco with an experienced leadership team hailing from Microsoft, Okta, Amazon, New Relic, Twitter and Oracle. For more information visit fauna.com or follow us at @fauna.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye